The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
2.
AI-based breast cancer risk technology receives FDA breakthrough device designation
3.
For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.
4.
Males with early-onset colorectal cancer are at risk, according to a study.
5.
Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis
1.
Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights
2.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
3.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
4.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
5.
Stomach Cancer: Uncovering the Subtle Signs and Symptoms
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
2.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation